Literature DB >> 6145950

51Cr-EDTA test for intestinal permeability.

P Selby, T J McElwain, M Crofts, N Lopes, J Mundy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6145950     DOI: 10.1016/s0140-6736(84)92018-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Gut protection by cyclophosphamide "priming" in patients receiving high-dose melphalan--effect of drug scheduling.

Authors:  J Mansi; E Ellis; C Viner; J Mundy; T Smith; J Millar; S Milan; M Gore; D Cunningham
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Population differences in intestinal permeability to chromium EDTA.

Authors:  S Bourke; B Murphy; F Stafford; K Maher; C O'Morain
Journal:  Ir J Med Sci       Date:  1988-09       Impact factor: 1.568

3.  Increased intestinal permeability in rats with graft versus host disease.

Authors:  W A Koltun; M M Bloomer; P Colony; G L Kauffman
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

4.  Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapy.

Authors:  P J Selby; N Lopes; J Mundy; M Crofts; J L Millar; T J McElwain
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

Review 5.  Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview.

Authors:  N M Blijlevens; J P Donnelly; B E De Pauw
Journal:  Bone Marrow Transplant       Date:  2000-06       Impact factor: 5.483

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.